Federal award
KBR WYLE SERVICES, LLC
0198
Contract
Obligated and Ceiling
- Obligated (net)
- $19,762,752.22
- Ceiling (potential value, not spending)
- $24,590,976.00
- Current value
- $24,590,976.00
- Gross positive obligations
- $23,347,894.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- KBR WYLE SERVICES, LLC · KNV8E5VRLHT9
- Owner company
- KBRBasis reviewed link: a dated, evidenced ownership link.
- Reported parent
- KBR, INC. · VJ3XVZC76HT9
- Awarding agency
- Department of Defense · sub-agency 9763 · office S0107A
- Funding agency
- Department of Defense · sub-agency 5700
- Product or service (PSC)
- AZ12 · R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541710 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES
- PIID
- 0198
- Parent vehicle (IDV PIID)
- HC104705D4005
- Award type code
- C
- Actions
- 31 · Aug 1, 2011 to Apr 5, 2019
- Why it is listed
- gross positive obligations of $100k or more (contracts); reviewed company, $10k or more
Action History31
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Apr 5, 2019 | FY2019 | 1C | C | −$24,479.50 | |
| Jan 18, 2018 | FY2018 | 1B | C | −$92,285.17 | |
| Mar 8, 2017 | FY2017 | 1A | C | −$434,520.11 | |
| Sep 21, 2015 | FY2015 | 27 | B | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Dec 5, 2014 | FY2015 | 26 | C | $167,660.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 27, 2014 | FY2014 | 25 | C | −$345,800.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 19, 2014 | FY2014 | 24 | C | $116,336.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 25, 2014 | FY2014 | 23 | C | $345,800.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 13, 2014 | FY2014 | 22 | C | −$53,307.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 2, 2014 | FY2014 | 21 | B | $46,900.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 24, 2014 | FY2014 | 20 | C | $152,953.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jan 23, 2014 | FY2014 | 19 | C | $111,516.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 30, 2013 | FY2013 | 18 | C | −$123,750.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 22, 2013 | FY2013 | 17 | C | $123,750.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 18, 2013 | FY2013 | 16 | C | −$1,400,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 9, 2013 | FY2013 | 15 | C | $200,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 12, 2013 | FY2013 | 14 | C | $262,401.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jan 2, 2013 | FY2013 | 13 | C | $118,826.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 26, 2012 | FY2012 | 12 | C | $205,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 23, 2012 | FY2012 | 11 | C | $450,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 1, 2012 | FY2012 | 10 | C | $872,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 24, 2012 | FY2012 | 9 | C | $132,892.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 27, 2012 | FY2012 | 8 | B | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 5, 2012 | FY2012 | 7 | C | $619,788.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 14, 2012 | FY2012 | 6 | C | $130,432.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jan 20, 2012 | FY2012 | 5 | C | −$1,111,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jan 3, 2012 | FY2012 | 4 | C | $552,230.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Dec 9, 2011 | FY2012 | 3 | C | $310,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 9, 2011 | FY2011 | 2 | C | $512,940.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 25, 2011 | FY2011 | 1 | C | $3,011,412.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 1, 2011 | FY2011 | 0 | — | $14,905,058.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.